Assisted Reproductive Technology through Artificial Intelligence
By Sumona Bose
March 6, 2024
Introduction
Since the first successful in vitro fertilisation (IVF) birth in 1978, assisted reproductive technology (ART) has advanced, aiding over eight million infertile couples in conceiving. The intricate protocols of IVF involve critical decision-making points handled by clinicians and embryologists, blending evidence-based choices with subjective judgments, shaping ART as both science and art. Artificial intelligence (AI) offers a promising avenue for optimising ART processes like drug selection, cycle monitoring, and embryo selection. Could this be a beginning to a future of unbelievable progress in the field of reproductive health?
Personalising ART with Machine Learning
Customising ART based on individual factors like ovarian reserve, genetic variations, and ethnic disparities can significantly impact treatment success. Machine learning (ML) methods enable tailoring treatment regimens to patient subgroups, optimising ovarian response, and luteal phase support. The integration of ML algorithms into clinical decision support systems (CDSS) harnesses the potential of electronic health records, offering personalised and data-driven approaches to enhance ART outcomes. As shown in Figure 1, the procedures involving ART are intricate, demanding thorough supervision. Clinicians and embryologists bear the responsibility for numerous crucial decision junctures both before and throughout the treatment cycle. AI contributes to this complex process with its data analysis skills.
Figure 1: Potential targets for the application of artificial intelligence and ML methods during clinical and embryological steps in ART. The order and timings of the steps can differ depending on the ART protocol used.
Transparency and Trust in AI Applications
The adoption of AI in ART faces challenges related to trust and interpretability, especially with complex ‘black-box’ models. Transparency emerges as a crucial factor in AI systems to ensure clinicians’ confidence in decision-making tools. Efforts to enhance explainability in AI models, particularly in image-based analyses in embryology, aim to provide insights into model reliability, fairness, and trustworthiness, paving the way for more widespread and effective use of AI in reproductive healthcare.
Conclusion
The integration of AI technologies holds immense promise in ART, offering personalised, data-driven, and transparent solutions to enhance the success rates and safety of assisted reproduction procedures. The blend of science and art in ART, with its intricate protocols and subjective decision-making, sets the stage for AI to make significant advancements in this field.
🚀 Is Europe poised to reclaim its leadership in life sciences by 2030?
The European Commission has unveiled a game-changing strategy aimed at transforming the EU into the world’s leading hub for life sciences, tackling critical challenges in health, biotechnology, and sustainability. With strategic investments and reforms, this initiative promises to bridge the innovation gap and enhance public health outcomes across the continent.
Curious about how these plans will impact the life sciences landscape? Explore the full insights of this exciting strategy!
🔍 Are we truly getting the full story on high-cost medications like ticagrelor?
A recent BMJ investigation has raised alarm bells over the integrity of data from pivotal studies on AstraZeneca’s ticagrelor, revealing significant misreporting and missing data that may undermine its clinical benefits. This exposes critical implications for health economics, regulatory oversight, and market access.
Curious about how these findings could reshape perceptions of drug efficacy and safety? Dive into the full article to uncover the truth behind the numbers.
🌍 Are we overlooking the power of self-care in Europe’s public health strategy?
The rise of self-care public health is reshaping how minor ailments are managed across the continent, leading to remarkable economic and productivity benefits. With annual savings of €36 billion and lifestyle improvements for consumers, self-care is proving to be a game-changer for healthcare systems.
Explore how embracing self-care can alleviate pressure on healthcare providers and enhance individual well-being. Dive into the full article to discover the implications for health economics and public policy!
#SyenzaNews #HealthEconomics #HealthcarePolicy
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management.
You’ll also feel our high-impact global and local perspectives with cultural intelligence.